Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects in First-Quarter 2012, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 03/27/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Theories abound regarding the , and the only fact that has emerged is it has changed and continues to do so. No construction, abundant construction, consolidation, expansion; oddly enough, all apply to this industry in transition. Sometimes, it helps to only deal with concrete facts, as in the construction concrete poured to build the 71 projects that wrapped up construction during the first quarter in North America.
Other companies featured: (NASDAQ:CBST), (NASDAQ:GRFS).
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.03.2012 - 04:30 Uhr
Sprache: Deutsch
News-ID 1096676
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 95 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects in First-Quarter 2012, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
